KEGG pathway screening (p < 0.05) identified 30 significantly enriched signaling pathways, including lipid and atherosclerosis, PI3K-Akt signaling, atherosclerosis, hepatitis B, diabetic complications, human cytomegalovirus infection, cellular senescence, small cell lung cancer, and endocrine resistance. This evidence concerns the gene AKT1 and small cell lung carcinoma.